Explore the Potential with AI-Driven Innovation
This extensive focused library is tailor-made using the latest virtual screening and parameter assessment technology, operated by the Receptor.AI drug discovery platform. This technique is more effective than traditional methods, offering compounds with improved activity, selectivity, and safety.
We carefully select specific compounds from a vast collection of over 60 billion molecules in virtual chemical space. Our partner Reaxense helps in synthesizing and delivering these compounds.
The library includes a list of the most promising modulators annotated with 38 ADME-Tox and 32 physicochemical and drug-likeness parameters. Also, each compound is presented with its optimal docking poses, affinity scores, and activity scores, providing a comprehensive overview.
Our top-notch dedicated system is used to design specialised libraries.
Fig. 1. The sreening workflow of Receptor.AI
Our methodology employs molecular simulations to explore a wide array of proteins, capturing their dynamic states both individually and within complexes. Through ensemble virtual screening, we address conformational mobility, uncovering binding sites within functional regions and remote allosteric locations. This thorough exploration ensures no potential mechanism of action is overlooked, aiming to discover novel therapeutic targets and lead compounds across an extensive spectrum of biological functions.
Our library is unique due to several crucial aspects:
partner
Reaxense
upacc
P17987
UPID:
TCPA_HUMAN
Alternative names:
CCT-alpha
Alternative UPACC:
P17987; E1P5B2; Q15556; Q5TCM3
Background:
T-complex protein 1 subunit alpha (CCT-alpha) is a crucial component of the chaperonin-containing T-complex (TRiC), a molecular chaperone complex vital for protein folding upon ATP hydrolysis. It plays a significant role in telomere maintenance by mediating the folding of WRAP53/TCAB1, and is involved in ciliogenesis by assisting in the assembly of the BBSome complex. Additionally, the TRiC complex is essential for the proper folding of actin and tubulin.
Therapeutic significance:
Understanding the role of T-complex protein 1 subunit alpha could open doors to potential therapeutic strategies.